Indaptus Therapeutics Inc. (INDP)
INDP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.39
-2.05% on the day
Market cap
$318.4M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | INDP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001857044 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-04 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEF 14A | 2026-07-16 |
Source: SEC EDGAR submissions feed, 338 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.8% |
| 1 month | -39.0% |
| 3 months | -12.3% |
| Year to date | -23.7% |
| 1 year | -44.9% |
| From 52-week high | -53.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CTNM | Contineum Therapeutics Inc. | $8.42 | -1.69% | $316.8M |
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
| ENTA | Enanta Pharmaceuticals Inc. | $11.52 | -6.34% | $335.5M |
| BNTC | Benitec Biopharma Inc. | $8.63 | -4.85% | $301.0M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
| IRD | Opus Genetics Inc. | $4.24 | -8.62% | $352.8M |
| EBS | Emergent BioSolutions Inc. | $6.91 | -1.00% | $354.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier